MYC and lymphoma: Consistent with this finding, both Myc-WT (Figure 6A) and MycC/+ (Figure 6B,C) -p53KO lymphoma allografts displayed a variable delay in emergence of detectable tumors in the tamoxifen-treated compared to control groups for the same primary tumor allografts.